During the past decade, Hospital Joan XXIII conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 13 clinical trials were completed, i.e. on average, 24.1% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 10 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Joan XXIII" #1 sponsor was "PETHEMA Foundation" with 22 trials, followed by "Institut Investigacio Sanitaria Pere Virgili" with 5 trials sponsored, "Hospital Universitari Joan XXIII de Tarragona." with 4 trials sponsored, "Hospital Universitari Vall d'Hebron Research Institute" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Joan XXIII" #1 collaborator was "Hospital Universitari Joan XXIII de Tarragona." with 4 trials as a collaborator, "University Rovira i Virgili" with 3 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "Hospital Universitari Sant Joan de Reus" with 2 trials as a collaborator and "Institut Investigacio Sanitaria Pere Virgili" with 2 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Joan XXIII" are "HIV Infections" (5 trials), "Multiple Myeloma" (5 trials), "Acute Lymphoblastic Leukemia" (4 trials), "Coronary Artery Disease" (3 trials) and "Acute Myeloid Leukemia" (2 trials). Many other conditions were trialed in "Hospital Joan XXIII" in a lesser frequency.

Most popular intervention types in "Hospital Joan XXIII" are "Drug" (56 trials), "Other" (20 trials), "Procedure" (9 trials), "Biological" (8 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Dexamethasone" (7 trials), "Prednisone" (5 trials), "Lenalidomide" (4 trials) and "Cytarabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Joan XXIII" are 97 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Joan XXIII". 3 are not yet recruiting, 12 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Hospital Joan XXIII, 2 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Joan XXIII, 5 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 17 trials that are defined as “Not Applicable".